Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fahn

Showing results (201-210 of 407) with videos related to

Pageof 41
Sort By:
Life Sciences|July 11, 1983
Lithium attenuates dopamine depleting effects of reserpine and tetrabenazine but not that of alpha methyl-p-tyrosineA Reches, M N Hassan, V R Jackson, et al.
Neurology|February 1, 1984
Pergolide therapy for Parkinson's disease: neurobehavioral changesY Stern, R Mayeux, J Ilson, et al.
Annals of Neurology|December 1, 1996
Selegiline and mortality in Parkinson's diseaseC W Olanow, S Fahn, J W Langston, et al.
Advances in Neurology|January 1, 1979
Anoxic myoclonus in the ratJ N Sharma, S R Snider, S Fahn, et al.
The Laryngoscope|February 1, 1988
Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia)A Blitzer, M F Brin, S Fahn, et al.
Life Sciences|March 15, 1977
Changes in adrenal dopamine concentration after metyrapone or ACTH administration: implications for the in vivo regulation of dopamine beta-hydroxylase by glucocorticoidsS R Snider, D Sahar, A L Prasad, et al.
Annals of Neurology|December 1, 1986
Correlates of early disability in Huntington's diseaseR Mayeux, Y Stern, A Herman, et al.
Brain Research|November 18, 1985
Presynaptic inhibition of dopamine synthesis in rat striatum: effects of chronic dopamine depletion and receptor blockadeA Reches, H R Wagner, V Jackson-Lewis, et al.
Neurology|February 1, 1997
Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's diseaseE D Louis, L A Klatka, Y Liu, et al.
Archives of Neurology|July 1, 1996
Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patientsS L Pullman, P Greene, S Fahn, et al.
Pageof 41

Showing results (201-210 of 407) with videos related to

Sort By:
Pageof 41
Life Sciences|July 11, 1983
Lithium attenuates dopamine depleting effects of reserpine and tetrabenazine but not that of alpha methyl-p-tyrosineA Reches, M N Hassan, V R Jackson, et al.
Neurology|February 1, 1984
Pergolide therapy for Parkinson's disease: neurobehavioral changesY Stern, R Mayeux, J Ilson, et al.
Annals of Neurology|December 1, 1996
Selegiline and mortality in Parkinson's diseaseC W Olanow, S Fahn, J W Langston, et al.
Advances in Neurology|January 1, 1979
Anoxic myoclonus in the ratJ N Sharma, S R Snider, S Fahn, et al.
The Laryngoscope|February 1, 1988
Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia)A Blitzer, M F Brin, S Fahn, et al.
Life Sciences|March 15, 1977
Changes in adrenal dopamine concentration after metyrapone or ACTH administration: implications for the in vivo regulation of dopamine beta-hydroxylase by glucocorticoidsS R Snider, D Sahar, A L Prasad, et al.
Annals of Neurology|December 1, 1986
Correlates of early disability in Huntington's diseaseR Mayeux, Y Stern, A Herman, et al.
Brain Research|November 18, 1985
Presynaptic inhibition of dopamine synthesis in rat striatum: effects of chronic dopamine depletion and receptor blockadeA Reches, H R Wagner, V Jackson-Lewis, et al.
Neurology|February 1, 1997
Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's diseaseE D Louis, L A Klatka, Y Liu, et al.
Archives of Neurology|July 1, 1996
Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patientsS L Pullman, P Greene, S Fahn, et al.
Pageof 41